Escilyf 5 Tablet contains Escitalopram Oxalate 5 mg, a selective serotonin reuptake inhibitor (SSRI) primarily indicated for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). Escitalopram functions by increasing the extracellular level of serotonin in the central nervous system, thereby enhancing serotonergic neurotransmission and improving mood and anxiety symptoms. It is prescribed to alleviate symptoms such as persistent sadness, loss of interest, fatigue, and excessive worry. The recommended dosage of Escilyf 5 Tablet should be individualized based on patient response and tolerability, with careful titration to minimize adverse effects. Common side effects may include nausea, headache, dry mouth, dizziness, and sleep disturbances, which are generally transient. Caution is advised in patients with a history of bipolar disorder, seizure disorders, or those taking monoamine oxidase inhibitors (MAOIs), due to the risk of serotonin syndrome. Escilyf 5 Tablet should be used under medical supervision, with regular monitoring for therapeutic efficacy and potential side effects. Abrupt discontinuation is discouraged to avoid withdrawal symptoms. This medication is contraindicated in patients with hypersensitivity to escitalopram or any components of the formulation. Pregnant or breastfeeding women should consult their healthcare provider before use.